A carregar...
Ustekinumab for the treatment of refractory pediatric Crohn’s disease: a single-center experience
BACKGROUND/AIMS: Despite the well-established efficacy of tumor necrosis factor (TNF) antagonists as treatment options for Crohn’s disease, many pediatric patients need a change in therapy due to adverse events and loss of response, highlighting the necessity for medications with a different mechani...
Na minha lista:
| Publicado no: | Intest Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Association for the Study of Intestinal Diseases
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8100375/ https://ncbi.nlm.nih.gov/pubmed/32312033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5217/ir.2019.09164 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|